MXPA04005549A - Bebida tratada con nicotina. - Google Patents
Bebida tratada con nicotina.Info
- Publication number
- MXPA04005549A MXPA04005549A MXPA04005549A MXPA04005549A MXPA04005549A MX PA04005549 A MXPA04005549 A MX PA04005549A MX PA04005549 A MXPA04005549 A MX PA04005549A MX PA04005549 A MXPA04005549 A MX PA04005549A MX PA04005549 A MXPA04005549 A MX PA04005549A
- Authority
- MX
- Mexico
- Prior art keywords
- nicotine
- mixture
- water
- process according
- filtering
- Prior art date
Links
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 title claims abstract description 60
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 title claims abstract description 49
- 229960002715 nicotine Drugs 0.000 title claims abstract description 49
- 235000013361 beverage Nutrition 0.000 title claims abstract description 10
- 239000000203 mixture Substances 0.000 claims abstract description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 238000010438 heat treatment Methods 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims description 15
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 11
- 238000001914 filtration Methods 0.000 claims description 9
- 229960001698 nicotine polacrilex Drugs 0.000 claims description 8
- 239000012528 membrane Substances 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 239000000779 smoke Substances 0.000 abstract description 7
- 239000000126 substance Substances 0.000 abstract description 5
- 241000208125 Nicotiana Species 0.000 description 5
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 4
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 description 4
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 239000003456 ion exchange resin Substances 0.000 description 4
- 229920003303 ion-exchange polymer Polymers 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000004695 Polyether sulfone Substances 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 208000015802 attention deficit-hyperactivity disease Diseases 0.000 description 3
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 description 3
- 229920006393 polyether sulfone Polymers 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 235000019504 cigarettes Nutrition 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 230000000391 smoking effect Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- MXYUKLILVYORSK-UHFFFAOYSA-N (+/-)-allo-lobeline Natural products C1CCC(CC(=O)C=2C=CC=CC=2)N(C)C1CC(O)C1=CC=CC=C1 MXYUKLILVYORSK-UHFFFAOYSA-N 0.000 description 1
- MXYUKLILVYORSK-HBMCJLEFSA-N (-)-lobeline Chemical compound C1([C@@H](O)C[C@H]2N([C@H](CCC2)CC(=O)C=2C=CC=CC=2)C)=CC=CC=C1 MXYUKLILVYORSK-HBMCJLEFSA-N 0.000 description 1
- RFEJUZJILGIRHQ-OMDKHLBYSA-N (2r,3r)-2,3-dihydroxybutanedioic acid;3-[(2s)-1-methylpyrrolidin-2-yl]pyridine Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.OC(=O)[C@H](O)[C@@H](O)C(O)=O.CN1CCC[C@H]1C1=CC=CN=C1 RFEJUZJILGIRHQ-OMDKHLBYSA-N 0.000 description 1
- AIBWPBUAKCMKNS-PPHPATTJSA-N 2-hydroxybenzoic acid;3-[(2s)-1-methylpyrrolidin-2-yl]pyridine Chemical compound OC(=O)C1=CC=CC=C1O.CN1CCC[C@H]1C1=CC=CN=C1 AIBWPBUAKCMKNS-PPHPATTJSA-N 0.000 description 1
- SDVKWBNZJFWIMO-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;3-(1-methylpyrrolidin-2-yl)pyridine Chemical compound CN1CCCC1C1=CC=CN=C1.OC(=O)CC(O)(C(O)=O)CC(O)=O SDVKWBNZJFWIMO-UHFFFAOYSA-N 0.000 description 1
- MQWJVKLIBZWVEL-XRIOVQLTSA-N 3-[(2s)-1-methylpyrrolidin-2-yl]pyridine;dihydrochloride Chemical compound Cl.Cl.CN1CCC[C@H]1C1=CC=CN=C1 MQWJVKLIBZWVEL-XRIOVQLTSA-N 0.000 description 1
- HDJBTCAJIMNXEW-PPHPATTJSA-N 3-[(2s)-1-methylpyrrolidin-2-yl]pyridine;hydrochloride Chemical compound Cl.CN1CCC[C@H]1C1=CC=CN=C1 HDJBTCAJIMNXEW-PPHPATTJSA-N 0.000 description 1
- YHBIGBYIUMCLJS-UHFFFAOYSA-N 5-fluoro-1,3-benzothiazol-2-amine Chemical compound FC1=CC=C2SC(N)=NC2=C1 YHBIGBYIUMCLJS-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001427367 Gardena Species 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- -1 alkaloid compounds Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003729 cation exchange resin Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000008369 fruit flavor Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229960002339 lobeline Drugs 0.000 description 1
- 229930013610 lobeline Natural products 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- BRTHFWPGJMGHIV-UHFFFAOYSA-L zinc;3-(1-methylpyrrolidin-2-yl)pyridine;dichloride;hydrate Chemical compound O.[Cl-].[Cl-].[Zn+2].CN1CCCC1C1=CC=CN=C1 BRTHFWPGJMGHIV-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/70—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter
- A23L2/72—Clarifying or fining of non-alcoholic beverages; Removing unwanted matter by filtration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Addiction (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33779001P | 2001-12-10 | 2001-12-10 | |
| US37238502P | 2002-04-15 | 2002-04-15 | |
| PCT/US2002/038655 WO2003049552A2 (en) | 2001-12-10 | 2002-12-04 | Beverage treated with nicotine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA04005549A true MXPA04005549A (es) | 2005-05-17 |
Family
ID=26990875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA04005549A MXPA04005549A (es) | 2001-12-10 | 2002-12-04 | Bebida tratada con nicotina. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7435749B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1461037B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2005526490A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20040062666A (cg-RX-API-DMAC10.html) |
| CN (1) | CN1602193A (cg-RX-API-DMAC10.html) |
| AT (1) | ATE368460T1 (cg-RX-API-DMAC10.html) |
| BR (1) | BR0214820A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2468785A1 (cg-RX-API-DMAC10.html) |
| DE (1) | DE60221568T2 (cg-RX-API-DMAC10.html) |
| EA (1) | EA010097B1 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2292837T3 (cg-RX-API-DMAC10.html) |
| MX (1) | MXPA04005549A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2003049552A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060105023A1 (en) * | 2001-12-10 | 2006-05-18 | Knight Joseph R | Treatment of neurological disorders with nicotine |
| WO2005018348A2 (en) * | 2003-08-11 | 2005-03-03 | William Whalen | Chewing tobacco substitute with nicotine |
| DE602005015446D1 (de) * | 2004-06-29 | 2009-08-27 | Fertin Pharma As | Tabakalkaloid freisetzendes kaugummi |
| US20110268809A1 (en) | 2010-04-28 | 2011-11-03 | Paul Andrew Brinkley | Nicotine-Containing Pharmaceutical Compositions |
| US20110274628A1 (en) | 2010-05-07 | 2011-11-10 | Borschke August J | Nicotine-containing pharmaceutical compositions |
| US20130078307A1 (en) | 2011-09-22 | 2013-03-28 | Niconovum Usa, Inc. | Nicotine-containing pharmaceutical composition |
| US9907748B2 (en) | 2011-10-21 | 2018-03-06 | Niconovum Usa, Inc. | Excipients for nicotine-containing therapeutic compositions |
| US9763928B2 (en) | 2012-02-10 | 2017-09-19 | Niconovum Usa, Inc. | Multi-layer nicotine-containing pharmaceutical composition |
| WO2016187277A1 (en) * | 2015-05-19 | 2016-11-24 | Joseph Robert Knight | Method for isolation of alkaloids and amino acids, and compositions containing isolated alkaloids and amino acids |
| US10532046B2 (en) | 2015-12-03 | 2020-01-14 | Niconovum Usa, Inc. | Multi-phase delivery compositions and products incorporating such compositions |
| US20170165252A1 (en) | 2015-12-10 | 2017-06-15 | Niconovum Usa Inc. | Protein-enriched therapeutic composition |
| DK3807260T3 (da) | 2018-06-15 | 2024-10-14 | Reynolds Tobacco Co R | Oprensning af nikotin |
| BR102020002169A2 (pt) * | 2020-01-31 | 2021-08-10 | Bruno Ghizoni Da Silva Comércio De Produtos E Serviços Inovadores-Me | Bebida estimulante |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2116308A (en) * | 1934-01-30 | 1938-05-03 | Standard Brands Inc | Beverage preparation |
| US2128043A (en) * | 1936-07-11 | 1938-08-23 | Hope Natural Gas Company | Process of extracting nicotine from tobacco |
| US2162738A (en) * | 1937-08-18 | 1939-06-20 | Clarence E Mccoy | Extracting nicotine from tobacco |
| US2293954A (en) * | 1938-06-21 | 1942-08-25 | Permutit Co | Recovery of nicotine |
| US2889049A (en) * | 1958-01-13 | 1959-06-02 | Florence E Hauser | Coffee filter |
| US3901248A (en) | 1970-07-22 | 1975-08-26 | Leo Ab | Chewable smoking substitute composition |
| GB8301659D0 (en) * | 1983-01-21 | 1983-02-23 | Leo Ab | Smoking substitutes |
| US4991599A (en) * | 1989-12-20 | 1991-02-12 | Tibbetts Hubert M | Fiberless tobacco product for smoking and chewing |
| US5135753A (en) | 1991-03-12 | 1992-08-04 | Pharmetrix Corporation | Method and therapeutic system for smoking cessation |
| AU750808B2 (en) | 1997-10-03 | 2002-07-25 | Cary Medical Corporation | Compositon for the treatment of nicotine addiction containing a nicotine receptor antagonist and an anti-depressant or anti-anxiety drug |
| CA2231968A1 (en) * | 1998-03-11 | 1999-09-11 | Smoke-Stop, A Partnership Consisting Of Art Slutsky | Method of producing a nicotine medicament |
| US6211194B1 (en) * | 1998-04-30 | 2001-04-03 | Duke University | Solution containing nicotine |
| US6268386B1 (en) * | 1998-06-25 | 2001-07-31 | Marshall Anlauf Thompson | Nicotine beverage |
| US6298859B1 (en) * | 1998-07-08 | 2001-10-09 | Novozymes A/S | Use of a phenol oxidizing enzyme in the treatment of tobacco |
| US6344222B1 (en) | 1998-09-03 | 2002-02-05 | Jsr Llc | Medicated chewing gum delivery system for nicotine |
| US6358060B2 (en) | 1998-09-03 | 2002-03-19 | Jsr Llc | Two-stage transmucosal medicine delivery system for symptom relief |
| US6472222B2 (en) | 1999-02-16 | 2002-10-29 | Via Christi Research, Inc. | Method of estimating rate of nicotine metabolism in individuals |
| US6749882B2 (en) * | 2000-05-17 | 2004-06-15 | Stephen Fortune, Jr. | Coffee having a nicotine composition dissolved therein |
| US6596740B2 (en) * | 2000-10-24 | 2003-07-22 | Richard L. Jones | Nicotine mucosal spray |
| US6479076B2 (en) | 2001-01-12 | 2002-11-12 | Izhak Blank | Nicotine delivery compositions |
| HUP0400094A3 (en) * | 2001-05-01 | 2005-03-29 | Regent Court Technologies Llc | Smokeless tobacco product |
-
2002
- 2002-12-04 CN CNA028246292A patent/CN1602193A/zh active Pending
- 2002-12-04 US US10/497,375 patent/US7435749B2/en not_active Expired - Fee Related
- 2002-12-04 MX MXPA04005549A patent/MXPA04005549A/es active IP Right Grant
- 2002-12-04 BR BR0214820-0A patent/BR0214820A/pt not_active IP Right Cessation
- 2002-12-04 CA CA002468785A patent/CA2468785A1/en not_active Abandoned
- 2002-12-04 EA EA200400792A patent/EA010097B1/ru not_active IP Right Cessation
- 2002-12-04 ES ES02791366T patent/ES2292837T3/es not_active Expired - Lifetime
- 2002-12-04 DE DE60221568T patent/DE60221568T2/de not_active Expired - Fee Related
- 2002-12-04 WO PCT/US2002/038655 patent/WO2003049552A2/en not_active Ceased
- 2002-12-04 JP JP2003550607A patent/JP2005526490A/ja active Pending
- 2002-12-04 AT AT02791366T patent/ATE368460T1/de not_active IP Right Cessation
- 2002-12-04 KR KR10-2004-7008386A patent/KR20040062666A/ko not_active Ceased
- 2002-12-04 EP EP02791366A patent/EP1461037B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EA010097B1 (ru) | 2008-06-30 |
| WO2003049552A2 (en) | 2003-06-19 |
| EP1461037A4 (en) | 2005-09-21 |
| JP2005526490A (ja) | 2005-09-08 |
| CN1602193A (zh) | 2005-03-30 |
| US20040248946A1 (en) | 2004-12-09 |
| EA200400792A1 (ru) | 2004-10-28 |
| US7435749B2 (en) | 2008-10-14 |
| DE60221568D1 (de) | 2007-09-13 |
| AU2002366598A1 (en) | 2003-06-23 |
| CA2468785A1 (en) | 2003-06-19 |
| ATE368460T1 (de) | 2007-08-15 |
| EP1461037A2 (en) | 2004-09-29 |
| EP1461037B1 (en) | 2007-08-01 |
| BR0214820A (pt) | 2005-08-30 |
| ES2292837T3 (es) | 2008-03-16 |
| DE60221568T2 (de) | 2008-04-17 |
| KR20040062666A (ko) | 2004-07-07 |
| WO2003049552A3 (en) | 2003-10-30 |
| HK1069769A1 (en) | 2005-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1461037B1 (en) | Process for preparation of a beverage treated with a nicotine containing substance | |
| TWI320697B (en) | Packaged beverages | |
| AU770309B2 (en) | Monoamine oxidase (MAO) inhibitors and uses thereof | |
| CA2968703A1 (en) | Method for isolation of alkaloids and amino acids, and compositions containing isolated alkaloids and amino acids | |
| DE102004060317A1 (de) | Abgepackte Getränke | |
| CN113973965B (zh) | 含茶氨酸复合物使人心情放松的压片糖果及其制备方法 | |
| JP5854767B2 (ja) | クロロゲン酸類含有飲料 | |
| AU2002366598B2 (en) | Beverage treated with nicotine | |
| TWI439231B (zh) | 綠茶萃取物之純化物之製造方法 | |
| HK1069769B (en) | Process for preparation of a beverage treated with a nicotine containing substance | |
| JP4102748B2 (ja) | 容器詰紅茶飲料 | |
| JP5028609B2 (ja) | 鉄補給組成物の製造方法 | |
| JP3648122B2 (ja) | 茶類飲料の製造方法 | |
| JPH07132073A (ja) | 飲料の香味劣化防止剤 | |
| US20060105023A1 (en) | Treatment of neurological disorders with nicotine | |
| JP2000069946A (ja) | ササ抽出液及びその製法 | |
| JP6567739B2 (ja) | 杜仲葉及び高麗人参抽出物を含む液体組成物、並びにその製造方法 | |
| CN116649563B (zh) | 一种用于分散灵芝粉的食品添加剂和灵芝粉快速分散方法 | |
| JP6367264B2 (ja) | 杜仲葉及び高麗人参抽出物を含む液体組成物、並びにその製造方法 | |
| JP6793507B2 (ja) | 活性炭及びカフェインを含有する飲料 | |
| JP2021093921A (ja) | 粉末緑茶抽出組成物 | |
| JPS60241849A (ja) | 酸性豆乳飲料の製造方法 | |
| JP2005130745A (ja) | 飲料およびその製造法 | |
| JPH09107935A (ja) | 松の芽エキスを含む合成飲料 | |
| WO2003000248A1 (en) | Liquid composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |